PVLA insider buying and SEC filings, explained
Palvella Therapeutics, Inc. · CIK 1583648
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- NV
- Fiscal year end
- Dec 31
- Former names
- PIERIS PHARMACEUTICALS, INC.; Marika Inc.
Insider activity in the last 12 months
Bought
$50K
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$13.8M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 21, 2026 | Planned (10b5-1) | Kathleen Goin (President / COO) sold 4,313 shares at about $124.58 ($537K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Oct 23, 2026, 4:05 PM ET |
| Oct 12–14, 2026 | Planned (10b5-1) | George M. Jenkins (Director) sold 27,500 shares between Oct 12 and Oct 14 at about $130.16 ($3.6M), marked as a 10b5-1 plan trade. Holdings down 17% to 132,616 shares. | SEC filing Filed Oct 14, 2026, 7:14 PM ET |
| Sep 16, 2026 | Planned (10b5-1) | Kathleen Goin (President / COO) sold 4,302 shares at about $152.24 ($655K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Sep 18, 2026 |
| Sep 11–15, 2026 | Planned (10b5-1) | George M. Jenkins (Director) sold 27,500 shares between Sep 11 and Sep 15 at about $151.53 ($4.2M), marked as a 10b5-1 plan trade. Holdings down 15% to 160,116 shares. | SEC filing Filed Sep 15, 2026 |
| Aug 19, 2026 | Planned (10b5-1) | Kathleen Goin (President / COO) sold 4,302 shares at about $152.21 ($655K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Aug 20, 2026 |
| Jul 15, 2026 | Planned (10b5-1) | Kathleen Goin (President / COO) sold 4,302 shares at about $149.28 ($642K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jul 17, 2026 |
| Jun 17, 2026 | Planned (10b5-1) | Kathleen Goin (President / COO) sold 4,302 shares at about $110.73 ($476K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jun 22, 2026 |
| May 20, 2026 | Planned (10b5-1) | Kathleen Goin (President / COO) sold 4,302 shares at about $110.56 ($476K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed May 22, 2026 |
| Apr 15, 2026 | Planned (10b5-1) | Kathleen Goin (President / COO) sold 4,302 shares at about $127.24 ($547K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Apr 17, 2026 |
| Mar 30, 2026 | Purchase (code P) | George M. Jenkins (Director) bought 445 shares at $112.30 ($50K), reported as a purchase (code P). Holdings up <1% to 187,616 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 1, 2026 |
| Mar 18, 2026 | Planned (10b5-1) | Kathleen Goin (President / COO) sold 4,302 shares at about $117.99 ($508K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Mar 20, 2026 |
| Feb 27, 2026 | Other purchase | George M. Jenkins (Director) bought 4,000 Common Stock at $125.00 ($500K) in a public offering. Holdings up 2% to 187,171 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 2, 2026 |
| Feb 27, 2026 | Other purchase | Elaine J. Heron (Director) bought 2,400 Common Stock at $125.00 ($300K) in a public offering. Holdings up 5% to 47,812 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 2, 2026 |
| Feb 18, 2026 | Planned (10b5-1) | Kathleen Goin (President / COO) sold 4,302 shares at about $79.40 ($342K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Feb 20, 2026 |
| Jan 21, 2026 | Planned (10b5-1) | Kathleen Goin (President / COO) sold 4,302 shares at about $97.63 ($420K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jan 23, 2026 |
| Dec 17, 2025 | Planned (10b5-1) | Kathleen Goin (President / COO) sold 4,302 shares at about $96.47 ($415K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Dec 19, 2025 |
| Nov 19, 2025 | Planned (10b5-1) | Kathleen Goin (President / COO) sold 4,302 shares at about $86.23 ($371K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Nov 21, 2025 |
28 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Oct 28, 2026, 7:30 AM ET 8-K | Other event (Item 8.01) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow PVLA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.